Arteris (AIP) Q1 2025: ACV Plus Royalties Rise 15% as Outsourcing Trend Accelerates

Arteris delivered record annual contract value plus royalties in Q1, underscoring intensifying customer migration toward commercial system IP solutions as chip complexity and economic volatility reshape the semiconductor landscape. Despite macro uncertainty and FX headwinds, management held full-year guidance, signaling confidence in robust deal flow and accelerating FlexGen adoption. Investors should focus on Arteris’ expanding role as a neutral system IP provider as the outsourcing vector gathers pace across AI, automotive, and enterprise end markets.

Summary

  • Outsourcing Momentum: Major chipmakers and OEMs are increasingly shifting system IP development to Arteris as complexity rises.
  • FlexGen Traction: Over 20 customer projects are evaluating FlexGen, with revenue impact expected to build from H2 2025.
  • Economic Uncertainty Response: Management widened guidance ranges but maintained midpoints, reflecting resilient demand and robust pipeline.

Performance Analysis

Arteris posted a 28% year-over-year revenue increase in Q1, driven by new design wins across AI, automotive, and enterprise segments. Record annual contract value plus royalties climbed 15% year-over-year, reaching $66.8 million, while remaining performance obligations (RPO) grew 19%. Gross margin remained industry-leading at 92% on a non-GAAP basis, reflecting the high-value, software-centric nature of Arteris’ system IP and automation portfolio.

Operating expenses rose modestly, up 8% year-over-year on a non-GAAP basis, mainly due to ongoing R&D and field engineering investments and FX-driven cost inflation. Operating leverage was evident as G&A spending stayed flat for three years, while targeted hiring supported product innovation and customer expansion. Free cash flow was positive in Q1, aided by early customer payments, and the company exited the quarter with $55.1 million in cash and no debt.

  • AI and Automotive Demand: Over half of new design starts tied to AI, with automotive and enterprise verticals leading royalty and contract growth.
  • FlexGen Pipeline Building: FlexGen, AI-driven NOC IP, is now in evaluation by more than 20 projects, with broad application across automotive, data center, and consumer markets.
  • Macro Factors Managed: FX headwinds and tariff-driven uncertainty prompted a wider guidance range, but no material change to growth trajectory or deal momentum.

Arteris’ mix is shifting toward higher-value, multi-year contracts as complexity and cost-of-internal development make outsourcing increasingly attractive for leading chipmakers and OEMs.

Executive Commentary

"We are seeing increased movement from internal system IP solutions to commercial vendors such as Arteris as customers desire resource efficiency, quality, and faster solutions delivery... our penetration of the increasingly complex microcontroller MCU system IP market continues with initial receipt of royalties from a top five MCU manufacturer."

Charlie Janik, Chief Executive Officer

"We plan to focus spending on strategically critical areas, in particular in key people who can help drive product development, enhance customer support through field application engineering, and expand the geographic and key account reach of our global sales team. We believe that these ongoing investments can accelerate our top-line growth."

Nick Hawkins, Chief Financial Officer

Strategic Positioning

1. FlexGen and Automation as Growth Catalysts

FlexGen, Arteris’ AI-driven NOC IP, is positioned as a step-change in engineering productivity and power efficiency for chip designers. With over 20 customer SOC projects now evaluating FlexGen, management expects it to begin contributing to bookings and annual contract value in the second half of 2025. The product’s broad applicability—from automotive to data center and edge AI—positions Arteris to capture share as chiplets and heterogeneous architectures proliferate.

2. Ecosystem Expansion and Standards Leadership

Arteris’ participation in the Intel Foundry Accelerator Program and IMEC Automotive Chiplet Forum signals a strategic push to align with emerging industry standards and multi-vendor chiplet ecosystems. By enabling physically aware NOCs for advanced process nodes and supporting interoperability, Arteris is cementing its role as a neutral, “Switzerland” provider of system IP critical to next-generation semiconductor design.

3. Outsourcing Trend Accelerates as Complexity Rises

Management highlighted a structural shift in the system IP market, with the share of outsourced commercial solutions expected to rise from one-third to two-thirds over time as internal development becomes uneconomic. Scarcity of engineering talent and the need for amortization of R&D across more projects are accelerating this trend, particularly as chiplet architectures and AI workloads drive up design complexity.

4. Operating Leverage and Disciplined Investment

G&A spending has remained flat for three years, while investments are targeted toward R&D and field engineering to support growth. This discipline is allowing Arteris to expand its global customer and support footprint—evidenced by the new Krakow, Poland engineering center—while preserving the ability to scale profitably as demand rises.

Key Considerations

This quarter marks a clear inflection in Arteris’ strategic positioning, as external market forces and rising design complexity drive a secular outsourcing wave in system IP. Investors should monitor the following:

Key Considerations:

  • FlexGen Revenue Timing: The full financial impact of FlexGen will manifest gradually, with bookings and ACV leading revenue recognition due to multi-year contract structures.
  • AI and Automotive Mix Shift: Over 55% of deals are now AI-related, with automotive and enterprise segments leading royalty growth—supporting a more resilient, diversified revenue base.
  • Exposure to Currency and Tariff Volatility: While Arteris is not directly tariffed, customer end-market volatility and FX-driven OPEX increases could pressure margins if macro conditions worsen.
  • Ecosystem Integration as Moat: Deepening ties with Intel Foundry and industry forums enhances Arteris’ positioning as standard-setter and partner of choice for complex, multi-die architectures.

Risks

Macro and geopolitical uncertainty, including tariffs and regulatory changes, create a less predictable end-market for Arteris’ customers, particularly in automotive and consumer verticals. FX headwinds may erode OPEX efficiency if the US dollar remains weak. While deal momentum remains strong, a sudden pullback in semiconductor capital spending or a slower-than-expected ramp of FlexGen could pressure near-term results.

Forward Outlook

For Q2 2025, Arteris guided to:

  • ACV plus royalties of $66 million to $70 million
  • Revenue of $16.1 million to $16.5 million
  • Non-GAAP operating loss of $4 million to $3 million
  • Non-GAAP free cash flow of negative $5 million to zero

For full-year 2025, management maintained guidance at the midpoint, with:

  • ACV plus royalties exiting 2025 at $71 million to $79 million
  • Revenue of $65 million to $71 million
  • Non-GAAP operating loss of $14 million to $7 million
  • Non-GAAP free cash flow of zero to positive $8 million

Management cited a robust deal pipeline and accelerating outsourcing interest among major customers, but widened ranges to reflect macro uncertainty and FX volatility.

Takeaways

Arteris is emerging as a critical enabler for next-generation chip design, with secular tailwinds from AI, chiplet adoption, and the outsourcing of system IP. The company’s disciplined investment and ecosystem partnerships position it to capture share as design complexity outpaces internal capabilities at major chipmakers.

  • Secular Outsourcing Shift: The move from internal to commercial system IP is accelerating, with Arteris benefiting from both complexity and scarcity of engineering talent.
  • FlexGen as Differentiator: Early customer traction and broad applicability suggest FlexGen could be a multi-year growth engine, especially as AI workloads proliferate.
  • Watch for Macro and FX Impact: Guidance ranges reflect real external risk, but core demand signals remain robust; investors should monitor deal flow and margin trends as leading indicators.

Conclusion

Arteris delivered record Q1 results and is strategically positioned to capitalize on the structural outsourcing trend in system IP, driven by AI, chiplet complexity, and industry standardization. While macro and FX risks remain, the company’s pipeline, product innovation, and ecosystem integration support a constructive long-term outlook.

Industry Read-Through

Arteris’ quarter underscores a broader semiconductor trend: as chip complexity and AI adoption surge, the economics of internal system IP development are breaking down, driving a secular shift to outsourcing. This dynamic benefits neutral, platform-agnostic vendors and raises the bar for internal teams at large chipmakers and OEMs. Industry standardization around chiplets and interoperability is accelerating, with ecosystem alliances like Intel’s Foundry Program setting the stage for multi-vendor collaboration. For design automation, EDA, and IP providers, the ability to deliver integrated, scalable, and physically aware solutions will define winners as the chiplet era matures.